Free Trial
→ Is SpaceX really worth 1.78 Trillion? (From InvestPub) (Ad)tc pixel Free TCBP Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

TC Biopharm (TCBP) Short Interest Ratio & Short Volume

TC Biopharm logo
Compare

TC Biopharm Short Interest Overview

As of February 28, 2025, TC Biopharm (TCBP) had a short interest of 49,400 shares sold short, representing 176.43% of the public float. This marks a -61.53% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.2, meaning it would take 0.2 days of the average trading volume of 177,918 shares to cover all short positions.

Current Short Interest
49,400 shares
Previous Short Interest
128,400 shares
Change Vs. Previous Month
-61.53%
Dollar Volume Sold Short
$96.33 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
410,000 shares
Short Percent of Float
176.43%
Today's Trading Volume
0 shares
Average Trading Volume
177,918 shares
Today's Volume Vs. Average
0%
Short Selling TC Biopharm?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for TC Biopharm and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TCBP Short Interest Over Time

TCBP Days to Cover Over Time

TCBP Percentage of Float Shorted Over Time

TC Biopharm Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/202549,400 shares $96.33 thousand -61.5%176.4%0.2 $1.95
2/15/2025128,400 shares $313.30 thousand +3,279.0%458.6%0.6 $2.44
1/31/20253,800 shares $28.20 thousand -98.8%N/A0 $7.42
1/15/2025318,300 shares $127.73 thousand +75.5%N/A0.1 $0.40
12/31/2024181,400 shares $93.60 thousand +474.1%N/A0.1 $0.52
12/15/202431,600 shares $16.72 thousand +65.5%N/A0 $0.53
11/30/202419,100 shares $10.69 thousand -50.1%N/A0 $0.56
11/15/202438,300 shares $25.35 thousand -41.0%N/A0 $0.66
10/31/202464,900 shares $85.67 thousand +293.3%N/A0.1 $1.32
10/15/202416,500 shares $83.99 thousand -14.1%N/A0 $5.09
9/30/202419,200 shares $100.99 thousand -71.0%N/A0.1 $5.26
9/15/202466,300 shares $434.93 thousand -3.2%N/A0.3 $6.56
8/31/202468,500 shares $381.55 thousand +126.8%N/A0.4 $5.57
8/15/202430,200 shares $109.93 thousand +480.8%N/A1.3 $3.64
7/31/20245,200 shares $31.93 thousand -84.2%N/A0.3 $6.14
7/15/202432,900 shares $26.24 thousand +130.1%N/A0 $0.80
6/30/202414,300 shares $11.79 thousand -42.6%N/A0 $0.82
6/15/202424,900 shares $25.90 thousand -56.6%N/A0 $1.04
5/31/202457,400 shares $61.99 thousand -56.3%N/A0 $1.08
5/15/2024131,200 shares $146.94 thousand -30.1%N/A0 $1.12
4/30/2024187,700 shares $268.41 thousand -21.0%N/A0 $1.43
4/15/2024237,600 shares $311.26 thousand +16.2%N/A0.1 $1.31
3/31/2024204,500 shares $267.90 thousand -68.0%N/A0 $1.31
3/15/2024638,700 shares $1.07 million +224.2%N/A0.2 $1.68
2/29/2024197,000 shares $250.19 thousand -5.1%N/A0.1 $1.27
2/15/2024207,500 shares $213.73 thousand +111.7%N/A0.3 $1.03
1/31/202498,000 shares $106.82 thousand +84.6%N/A0.1 $1.09
1/15/202453,100 shares $135.41 thousand +127.9%N/A0.4 $2.55
12/31/202323,300 shares $73.86 thousand -45.7%N/A0.2 $3.17
12/15/202342,900 shares $110.68 thousand -88.2%N/A0.6 $2.58
11/30/2023364,400 shares $134.06 thousand +1,312.4%N/A0.5 $0.37
11/15/202325,800 shares $13.27 thousand -84.3%N/A0 $0.51
10/31/2023164,000 shares $70.52 thousand -11.4%N/A0.5 $0.43
10/15/2023185,000 shares $68.75 thousand +2,334.2%N/A0.5 $0.37
9/30/20237,600 shares $3.27 thousand -84.9%N/A0 $0.43
9/15/202350,400 shares $23.70 thousand +45.2%N/A0.1 $0.47
8/31/202334,700 shares $19.43 thousand -16.2%N/A0.1 $0.56
8/15/202341,400 shares $22.22 thousand -52.9%N/A0.1 $0.54
7/31/202387,900 shares $54.50 thousand -53.3%N/A0.1 $0.62
7/15/2023188,100 shares $96.58 thousand -17.1%N/A0.4 $0.51
No. You’re not imagining it… (Ad)

Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Watch Porter Stansberry's full briefing and learn how to prepare now
6/30/2023226,900 shares $122.98 thousand -26.4%N/A0.4 $0.54
6/15/2023308,100 shares $188.53 thousand +581.6%N/A1 $0.61
5/31/202345,200 shares $36.73 thousand -6.8%N/A0.2 $0.81
5/15/202348,500 shares $36.33 thousand -62.3%N/A0.2 $0.75
4/30/2023128,500 shares $142.64 thousand +114.9%N/A0.4 $1.11
4/15/202359,800 shares $83.12 thousand -27.1%N/A0.1 $1.39
3/31/202382,000 shares $131.20 thousand +821.4%N/A0.1 $1.60
3/15/20238,900 shares $32.84 thousand -88.0%N/A0 $3.69
2/28/202374,100 shares $312.70 thousand +96.6%N/A0.1 $4.22
2/15/202337,700 shares $262.02 thousand -44.5%N/A0 $6.95
1/31/202367,900 shares $347.65 thousand -42.7%N/A0.1 $5.12
1/15/2023118,400 shares $530.43 thousand +1,096.0%N/A0.2 $4.48
12/30/20229,900 shares $38.12 thousand +98.0%N/A0.2 $3.85
12/15/20225,000 shares $21.15 thousand -15.3%N/A0.3 $4.23
11/30/20225,900 shares $27.79 thousand +110.7%N/A0.4 $4.71
11/15/20222,800 shares $23.80 thousand -98.1%N/A0.2 $8.50
10/31/2022148,500 shares $25.99 thousand +89.9%N/A0.7 $0.18
10/15/202278,200 shares $17.24 thousand -64.1%N/A0.2 $0.22
9/30/2022217,600 shares $61.04 thousand -8.2%N/A0.6 $0.28
9/15/2022236,900 shares $77.02 thousand +51.7%N/A0.6 $0.33
8/31/2022156,200 shares $51.22 thousand -20.6%N/A0.3 $0.33
8/15/2022196,800 shares $83.17 thousand +261.8%N/A0.2 $0.42
7/31/202254,400 shares $19.62 thousand -68.8%N/A0.1 $0.36
7/15/2022174,600 shares $69.23 thousand No ChangeN/A0.2 $0.40

TCBP Short Interest - Frequently Asked Questions

Short interest is the volume of TC Biopharm shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 49,400 shares of TCBP short. 176.43% of TC Biopharm's shares are currently sold short. Learn More on TC Biopharm's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCBP shares currently have a short interest ratio of 0.2. Learn More on TC Biopharm's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 176.43% of TC Biopharm's floating shares are currently sold short.

TC Biopharm saw a decline in short interest in February. As of February 28th, there was short interest totaling 49,400 shares, a decline of 61.5% from the previous total of 128,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

176.43% of TC Biopharm's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TC Biopharm: Aditxt, Inc. (11.44%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), Strategy Inc ($6.56 billion), Apollo Global Management Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Corporation ($4.45 billion), Capital One Financial Corporation ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), SLB Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

Short selling TCBP is an investing strategy that aims to generate trading profit from TC Biopharm as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for TC Biopharm occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCBP, twice per month. The most recent reporting period available is February, 28 2025.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TCBP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:TCBP) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
Is your wealth prepared for “America’s Most Dangerous Man”? (Read before June 16)
60-year Wall Street veteran Marc Chaikin is issuing an urgent warning about the billionaire behind an AI lab t...
Chaikin Analytics | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Live demo of Elon Musk’s AI agent
Jeff Brown picked Nvidia in 2016 - it's up 25,155%. He recommended Bitcoin at $240 - it's up 31,219%. Now he's...
Brownstone Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
This Is How Financial Freedom Dies—And Most People Never See It Coming
While the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...
Priority Gold | Sponsoredtc pixel
Jon Najarian: “Make this move now that SPCX is trading”
SpaceX is now publicly trading under the ticker SPCX - but Hall of Fame Trader Jon Najarian says the real oppo...
Banyan Hill Publishing | Sponsoredtc pixel